The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance
Open accessAbstract
Tuberculosis (TB) is one of the world's most important infectious causes of morbidity and mortality among adults. Between 8 and 9 million develop TB disease, and approximately 2 million die from TB each year. Despite this enormous global burden, case detection rates are low, posing major hurdles for TB control. Conventional TB diagnosis continues to rely on smear microscopy, culture and chest radiography. These tests have known limitations. Conventional tests for detection of drug resistance are slow, tedious and difficult to perform in field conditions. This second half of a two-part review series on new tools for TB diagnosis describes recent advances and emerging technologies in the diagnosis of active disease, and detection of drug resistance. For diagnosis, new tools include newer versions of nucleic acid amplification tests, immune-based assays, skin patch test and rapid culture systems. For drug resistance, new tools include line-probe assays, bacteriophage-based assays, molecular beacons and microscopic observation drug susceptibility assay. Although the ideal test for TB is still not in sight, substantial progress has been made in the past decade. With the resurgence of interest in the development of new tools for TB control, it is likely that the next decade will see greater progress and tangible benefits. However, the challenge will be to ensure that new tools undergo rigorous evaluations in field conditions, and also to make sure that benefits of promising new tools actually reach the populations in developing countries that need them most. Latent TB is discussed in Part I; 413-422 of this issue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pai, M., Flores, L. L., Pai, N., Hubbard, A., Riley, L. W., & Colford, J. M. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00772-2 · Cited by 384
Self-citationProperties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG
Harboe, M., Nagai, S., Patarroyo, M. E., Torres, M. L., Ramirez, C., & Cruz, N. (1986) · Infection and Immunity · doi:10.1128/iai.52.1.293-302.1986 · Cited by 207
Cited by
Gopalaswamy, R., Shanmugam, S., Mondal, R., & Subbian, S. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00667-6 · Cited by 350
Boehme, C. C., Nabeta, P., Henostroza, G., Raqib, R., Rahim, Z., Gerhardt, M., Sanga, E., Hoelscher, M., Notomi, T., Hase, T., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02352-06 · Cited by 341
International Standards for Tuberculosis Care
Hopewell, P. C., Pai, M., Maher, D., Uplekar, M., & Raviglione, M. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70628-4 · Cited by 336
Self-citationTheron, G., Peter, J., van Zyl-Smit, R., Mishra, H., Streicher, E., Murray, S., Dawson, R., Whitelaw, A., Hoelscher, M., Sharma, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0056oc · Cited by 311
Self-citationTuberculosis contact investigation in low prevalence countries: a European consensus
Erkens, C. G. M., Kamphorst, M., Abubakar, I., Bothamley, G. H., Chemtob, D., Haas, W., Migliori, G. B., Rieder, H. L., Zellweger, J.-P., & Lange, C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00201609 · Cited by 272
Metadata
- Authors
- Pai, M., Kalantri, S., & Dheda, K.
- Venue
- Expert Review of Molecular Diagnostics
- Publisher
- Informa UK Limited
- Published
- 2006-05
- Volume
- 6
- Issue
- 3
- Pages
- 423-432
- ISSN
- 1473-7159 (ISSN-L)
- 1744-8352
- OpenAlex
- W2170504449
- Cited by
- 193
- References
- 2
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance. https://app.cochat.ai/papers/10.1586/14737159.6.3.423
- The paper
- Pai, M., Kalantri, S., & Dheda, K. (2006). New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance. Expert Review of Molecular Diagnostics. https://doi.org/10.1586/14737159.6.3.423
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.